Trial
NCT05178342
Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Leipzig
Collaborators
Curis, Inc.
Condition
Myelodysplastic Syndromes
Intervention
CA-4948
Why stopped
Prematurely according to trial protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-13